Cargando…
Clinical sequencing using a next‐generation sequencing‐based multiplex gene assay in patients with advanced solid tumors
Advances in next‐generation sequencing (NGS) technologies have enabled physicians to test for genomic alterations in multiple cancer‐related genes at once in daily clinical practice. In April 2015, we introduced clinical sequencing using an NGS‐based multiplex gene assay (OncoPrime) certified by the...
Autores principales: | Kou, Tadayuki, Kanai, Masashi, Yamamoto, Yoshihiro, Kamada, Mayumi, Nakatsui, Masahiko, Sakuma, Tomohiro, Mochizuki, Hiroaki, Hiroshima, Akinori, Sugiyama, Aiko, Nakamura, Eijiro, Miyake, Hidehiko, Minamiguchi, Sachiko, Takaori, Kyoichi, Matsumoto, Shigemi, Haga, Hironori, Seno, Hiroshi, Kosugi, Shinji, Okuno, Yasushi, Muto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497931/ https://www.ncbi.nlm.nih.gov/pubmed/28440963 http://dx.doi.org/10.1111/cas.13265 |
Ejemplares similares
-
Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer
por: Kondo, Tomohiro, et al.
Publicado: (2018) -
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2019) -
Inter-assay variability of next-generation sequencing-based gene panels
por: Quy, Pham Nguyen, et al.
Publicado: (2022) -
Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
por: Mitani, Yosuke, et al.
Publicado: (2020) -
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022)